Fully biodegradable nutraceutical packaging an industry first
An agreement signed between TricorBraun and BioBottles will give nutraceutical companies (and potentially pharmaceutical companies) in the US and Canada access to the industry’s first fully biodegradable packaging option.
American packaging designer and distributor TricorBraun have signed an exclusive agreement with BioBottlesTM to offer their biodegradable bottles to the nutraceutical industry, the first and only bottle of its kind for nutraceutical companies in the US and Canada.
In an effort to expand their current sustainable packaging offerings, the agreement will allow TricorBraun to exclusively offer BioBottles in the US and Canada. Made with proprietary technology, BioBottles offer nutraceutical companies and contract organisations an environmentally responsible alternative at a cost-effective price point, with scope to be utilised in pharmaceutical packaging needs.
“Sustainability matters to our customers and their consumers, and it matters to TricorBraun,” Mark O’Bryan, COO at TricorBraun, stated. “Our exclusive BioBottles agreement in another example of our focused efforts to offer comprehensive sustainable options for our customers. We are thrilled to partner with BioBottles to provide our customers with a solution that helps protect both their products and the planet.”
Manufacturered utilising Plastic IQTM technology, BioBottles and BioCapTM transforms HDPE and PP bottles, caps, scoops, and other items into a material that, when discarded, begins to degrade when exposed to UV, oxygen, and microorganisms. Fungi and bacteria are stimulated into treating the material as a food source and consume and fully degrade the packaging. BioBottles claims to leave behind no microplastics and convert into oxygen, carbon dioxide, and biomass, offering nutraceutical and pharmaceutical companies an industry-first, fully biodegradable packaging solution.
CEO and co-founder of BioBottles James Vanbrocklin commented on the partnership: “TricorBraun shares our dedication and commitment to providing sustainable packaging options for the benefit of the planet... We are excited to partner with a respected industry leader like TricorBraun to deliver this unique yet sustainable alternative for nutraceutical companies, and we look forward to working with TricorBraun to expand into new markets.”
Related News
-
News Ardena forms partnership with RiboPro to improve mRNA-based therapies
Ardena and RiboPro have formed an alliance to boost their respective skills in manufacturing and producing nanoparticle and mRNA-based therapeutics to improve accessibility to this technology in the biotherapeutic landscape. -
News Updated: Samsung Biologics to manufacture Pfizer's biosimilars products
Samsung Biologics agrees to use their biocampus Plant 4 for the manufacture of a line of products from Pfizer. -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Soft capsule technology: modified pea starch as a vegetal origin alternative to gelatin in capsule shell
The latest soft capsule technology from Roquette using modified pea starch as an alternative to gelatin. -
News Your Prescription for Marketing Success: Digital Pharma Marketing Toolkit – Free eBook
Download your FREE pharma marketing eBook to learn why it is so important for pharmaceutical marketeers to develop their digital content marketing strategies in order to establish their companies as thought leaders and industry experts. -
News High demand: Vetter expands production capacities and services offered at its Austrian site
Pharma service provider further expands offerings for clinical development and manufacturing -
News Novavax will provide adjuvant Matrix-M for vaccine research with 3-year partnership
Novavax, developers behind the Matrix-M adjuvant, have entered into an agreement with the Bill and Melinda Gates Medical Research Institute to provide the adjuvant in preclinical vaccine research.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance